Moderna Therapeutics Clinical Manufacturing Facility, Norwood
Moderna is adding another country to its production network
Moderna Therapeutics' cGMP Clinical Manufacturing Facility, Built by Wise, Chosen as FOYA Finalist | Wise Construction
Moderna Therapeutics News, Reviews & Resources - Labiotech.eu
Moderna Gets OK to Start Larger Trial for a Coronavirus Vaccine - The New York Times
Moderna to partner with ElevateBio on CRISPR research
Moderna Raises Size of its Largest-Ever Biotech IPO to $600M
Moderna Therapeutics Clinical Manufacturing Facility, Norwood
Moderna, Catalent partner on COVID-19 vaccine candidate manufacturing - Medical Design and Outsourcing
Moderna caps off busy week with $1.2B CytomX collaboration
Moderna (@moderna_tx) / Twitter
Moderna's Stock Has Tripled on Vaccine News. Is It a Buy? | Barron's
When a Harvard Alum is the CEO of Moderna Therapeutics, in the Race for the COVID-19 Vaccine — HARVARD ALUMNI ENTREPRENEURS
Moderna Is Manufacturing Its Potential Coronavirus Vaccine With Unusual Speed | WBUR News
Moderna and Carisma Establish Collaboration to Develop in vivo Engineered Chimeric Antigen Receptor Monocytes (CAR-M) for Oncology | Leukemia and Lymphoma Society
Moderna and CytomX to partner in deal worth up to 1.2bn - PMLiVE
Moderna CEO sees 'high probability' of success with Covid-19 vaccine
Science by press release': Sudden rise of vaccine developer Moderna rankles some in scientific establishment - ABC News
Moderna Archives - Knowledge Ecology International
Moderna Files for Largest-Ever Biotech IPO, Seeking to Raise $500M
Investor Relations Overview
FDA Researchers Endorse Moderna COVID-19 Vaccine | KQED
Deliver mRNA Drugs Faster, at Lower Cost Using AWS | Moderna Therapeutic Case Study | AWS
DPS and TRIA Selected to Design 200,000 SF GMP mRNA Clinical Manufacturing Facility for Moderna Therapeutics - TRIA
Moderna Therapeutics Raises Record $450M for Messenger RNA Drugs - WSJ
Biotech unicorn Moderna Therapeutics' $110 Norwood site built with expansion hopes - Boston Business Journal
Moderna Vaccine Trial: How Upbeat Coronavirus News Fueled a Stock Surge - The New York Times
